TIDMAHI 
 
RNS Number : 0017D 
Allied Healthcare International Inc 
24 November 2009 
 
? 
Allied Healthcare International Inc. Reports Fiscal 2009 Fourth Quarter and 
Year-End Results 
 
 
Fourth Quarter Revenues Increase 8.4%, at Constant Exchange Rates 
 
 
Fourth Quarter Operating Income Increases 16.1%, at Constant Exchange Rates 
 
 
Fiscal 2009 Revenues Increase 6.4%, at Constant Exchange Rates 
 
 
Fiscal 2009 Operating Income Increases 37.5%, at Constant Exchange Rates 
 
 
NEW YORK, NY--(Marketwire - November 24, 2009) - Allied Healthcare International 
Inc. (NASDAQ: AHCI) (AIM: AHI) 
 
 
 
 
 
 
                                                     Fourth      Twelve 
 (In 
millions, except EPS)                           Quarter      Months 
 
                                         -----------  ----------- 
 Revenues, 
as reported                             $      69.8  $     249.8 
 Revenues, 
at constant exchange rates              $      81.2  $     317.7 
 Gross 
Profit, as reported                         $      21.2  $      76.3 
 Gross 
Profit, at constant exchange rates          $      24.6  $      97.1 
 Gross 
Profit %                                           30.3% 
30.6% 
 
Operating Income, as reported                     $       4.2  $ 
13.1 
 
Operating Income, at constant exchange rates      $       5.0  $ 
17.5 
 
Diluted EPS, continuing operations                $      0.07  $ 
0.22 
 


-----------

=---------- 
 
Allied Healthcare International Inc. (http://www.alliedhealthcare.com), a 
leading provider of flexible healthcare staffing services in the United Kingdom, 
has issued financial results for its fiscal 2009 fourth quarter and year-end. 
 
 
To provide investors with an increased understanding of the Company's business, 
Allied is providing a breakdown of its revenues, gross profits, selling, general 
and administrative ("SG&A") costs and operating income at constant exchange 
rates using the comparable prior period weighted average exchange rate. Further, 
the discussions below as to the fiscal 2009 fourth quarter and year end 
comparative analysis with the prior year results also take into account constant 
exchange rates. In addition, as the Company's revenues and gross profits are 
generated in the United Kingdom, an analysis is included, within the management 
discussion below, of the last eight quarters' revenues and gross profits in 
pounds sterling to enable investors to fully understand the underlying trends 
over these periods without the effects of currency exchange rates. As noted in 
the reported numbers, recent fluctuations in foreign exchange rates have 
significantly impacted the Company's current period results. 
 
 
Fiscal Fourth Quarter Results: 
 
 
 
 
 
 
For the fourth quarter of fiscal 2009 revenues increased by $6.3 million, or 
8.4%, to $81.2 million, compared with $75.0 million reported during the same 
period in fiscal 2008. Contributing to the increase in revenues was Allied's 
Homecare revenues, which grew by 18.5% to $68.1 million. Nursing Homes revenues 
declined by 22.5% to $7.5 million. Hospitals revenues decreased by 28.2% to $5.6 
million. After the unfavorable impact of currency exchange of $11.4 million, 
revenues decreased to the reported $69.8 million. 
 
 
Total gross profit for the fourth fiscal quarter increased 7.5% to $24.6 
million, compared with $22.9 million reported for the comparable quarter in 
fiscal 2008. Gross profit percent for the fourth quarter was 30.3%, as compared 
to 30.6% for the comparable prior period. Foreign exchange decreased gross 
profit by $3.4 million to the reported $21.2 million for the quarter. 
 
 
SG&A for the fourth fiscal quarter was $19.6 million, compared with $18.6 
million reported last year, an increase of 5.5%. As a percent of revenues, SG&A 
costs were 24.4%, compared to 24.8% in the comparable prior year period. Foreign 
exchange decreased costs by $2.6 million to the reported $17.0 million for the 
quarter. 
 
 
Operating income for the fourth quarter of fiscal 2009 increased to $5.0 
million, compared to operating income of $4.3 million reported during the 2008 
fourth fiscal quarter. Foreign exchange decreased operating income by $0.8 
million to the reported $4.2 million for the quarter. 
 
 
Net income for the fourth quarter of fiscal 2009 was $2.9 million, as compared 
with $2.9 million reported during the 2008 fourth fiscal quarter. Diluted 
earnings per share was $0.07 for the quarter, compared to diluted earnings per 
share of $0.06 last year. 
 
 
Fiscal 2009 Full Year Results: 
 
 
For the year ended September 30, 2009 revenues increased by $19.1 million, or 
6.4%, to $317.7 million, compared with $298.6 million reported during the same 
period in fiscal 2008. Contributing to the increase in revenues was Allied's 
Homecare revenues, which grew by 15.0% to $259.3 million. Nursing Homes revenues 
declined by 21.4% to $32.9 million. Hospitals revenues decreased by 18.4% to 
$25.5 million. After the unfavorable impact of currency exchange of $67.9 
million, revenues decreased to the reported $249.8 million. 
 
 
Total gross profit for the year ended September 30, 2009, increased 7.4% to 
$97.1 million, compared with $90.4 million reported for the comparable period in 
fiscal 2008. Gross profit percent for the year ended September 30, 2009, 
increased to 30.6% from 30.3% for the comparable prior period. Foreign exchange 
decreased gross profit by $20.8 million to the reported $76.3 million for the 
year. 
 
 
SG&A for the year ended September 30, 2009, was $79.6 million, compared with 
$77.7 million reported last year, an increase of 2.5%. As a percent of revenues, 
SG&A costs were 25.3% compared to 26.0% in the comparable prior year period. 
Foreign exchange decreased costs by $16.4 million to the reported $63.2 million 
for the year. 
 
 
Operating income for the year ended September 30, 2009, increased to $17.5 
million, compared to operating income of $12.7 million reported during the 
comparable prior year period, an increase of 37.5% over the prior year. Foreign 
exchange decreased operating income by $4.4 million to the reported $13.1 
million for the year. 
 
 
Income from continuing operations for the year ended September 30, 2009, 
increased to $9.9 million, as compared with $8.8 million reported for the year 
ended September 30, 2008. Diluted earnings per share from continuing operations 
was $0.22 for the fiscal year ended September 30, 2009, compared to diluted 
earnings per share from continuing operations of $0.19 last year. 
 
 
Net income for the year ended September 30, 2009, increased to $10.3 million, as 
compared with $8.8 million reported during the 2008 fiscal year. Diluted 
earnings per share was $0.23 for the year ended September 30, 2009, which 
includes $0.01 from discontinued operations due to the release of reserves as a 
result of the warranty period within the sales agreement, related to the sale of 
the respiratory business in fiscal 2007, having expired. This compares to $0.19 
for the year end September 30, 2008. 
 
 
At September 30, 2009, and September 30, 2008, Allied's cash balance was $35.3 
million (GBP22.2 million) and $26.2 million (GBP14.4 million), respectively, 
representing an underlying increase in the cash balance of $9.1 million (GBP7.8 
million). 
 
 
For the year ended September 30, 2009, depreciation and amortization was $3.8 
million (GBP2.5 million) and capital expenditures were $2.9 million (GBP1.8 
million). Days Sales Outstanding was twenty-five days at September 30, 2009 (40 
days including unbilled account receivables), and twenty-one days at September 
30, 2008 (40 days including unbilled account receivables). 
 
 
Management Discussion: 
 
 
"We continue to see good growth in our homecare business, which now represents 
over 80% of our business," commented Sandy Young, Chief Executive Officer of 
Allied. "The homecare revenue growth in the quarter of 18.5% was particularly 
pleasing and was ahead of our 10-15% growth range expectation. The Company's 
homecare business should benefit from many favorable market dynamics. These 
include: an aging population; continued shift from residential care to homecare; 
the lower cost of private business homecare provision; and continued 
consolidation of local authority suppliers. These factors all favor a growth in 
demand in our core homecare business." 
 
 
Mr. Young continued: "Even the anticipated further tightening of the local 
government and National Health Service (NHS) budgets over the next few years, as 
the government addresses its financial deficit, provides an opportunity for us. 
We believe that the demonstrated financial benefits of lower costs that have and 
can continue to be achieved by homecare, as compared to institutional care, 
should be a strong incentive for local governments and NHS Primary Care Trusts, 
in addressing the ongoing financial challenges they face. 
 
 
"While our nursing homes and hospital staffing business results were higher in 
the fourth quarter as compared to the third quarter, which is a similar trend as 
in the prior year, we continue to look for opportunities for these businesses. 
As previously reported, we were successfully awarded the new NHS framework 
agreements, which came into effect on October 1, 2009. We have started to enact 
the higher pay and charge rates under the new framework agreements which we 
believe are essential to effectively recruit and retain staff to service this 
business. Expanding upon our existing London operation, we have recently agreed 
to lease a Midlands regional office, from which we hope to start business from 
in 2010 to service the hospital staffing demand in the central regions of 
England. 
 
 
"Our current period SG&A running costs of 24.4% of revenues compares to 25.8% in 
the prior quarter. We are continuing, as previously reported, to invest in 
certain areas of our business that include such items as continuing care, 
learning disabilities, IT systems, training, and business improvement projects 
to ensure that we support future growth in revenues. At the same time, we 
maintain tight controls over other areas of SG&A costs so as to maintain our 
objective of reducing SG&A costs as a percent of revenues. Our investment in 
training also allows us to qualify for currently available government training 
grants, which have given us a net financial benefit of $0.6 million as compared 
to the prior year. 
 
 
"We are pleased with the progress we have made in the year in the key area of 
carer and branch staff retention, staff development and support, the progress of 
our coldharbour IT system rollout, and our attention to service and quality 
delivery, all of which, we believe, create a strong foundation for future growth 
for our business. As well as our focus in the quarter on service and quality, 
which we believe is essential and a key driver to increased revenue and profit 
growth, we have been actively looking at acquisition opportunities. Any such 
acquisitions will be reviewed in conjunction with our Capital Resources Review, 
which also includes looking at other opportunities to enhance shareholder value. 
 
 
"We recently re-launched our website which includes details of our key service 
offerings and also gives case studies of some of the work the Company is 
currently involved in. In addition, our recent major contract wins, our network 
of branches, which include three new branches in the London region and one new 
branch in Scotland following our successful contract wins, our quality and 
governance standards, our investor relations links and our employee and 
recruitment information have all been updated and enhanced. We believe that our 
current and prospective customers, employees and investors will find our new 
website informative and helpful. 
 
 
"We have also appointed ICR, LLC as our investor relations firm effective 
December 2009, which, we believe, will help us to develop further our 
relationships with existing and new shareholders." 
 
 
Mr. Young concluded: "Overall, we are positive about the year ahead. The 
business has a more robust operating platform and many of the business 
improvement initiatives have yet to be fully implemented. We believe that the 
extra investment we have made this year in learning disabilities and continuing 
care will help support our top line growth in homecare." 
 
 
Paul Weston, Chief Financial Officer of Allied, commented: "As noted in our 
previous quarter's press release, with nearly all our operations in the United 
Kingdom, we believe it is important for investors to see the underlying revenues 
and gross profits in pound currency as detailed below. This shows growth in our 
gross profits year to date of 7.4%, and our fourth quarter gross profit of 30.3% 
is in line with our expectations. Our SG&A costs year to date, excluding 
exchange effects, increased by 2.5% compared to the prior year which compares 
favorably with the revenue growth of 6.4% that we have generated." 
 
 
 
 
Dr. Jeffrey Peris, Non-Executive Chairman of the Board of Allied, commented: 
"Sandy Young and the management team have achieved operating income for the year 
of $17.5 million, excluding exchange, which compares to $12.7 million for the 
prior year. This is an increase of 37.5%, and reflects the continued 
improvements the Company is making across its business to help it affirm its 
position as one of the leaders in the U.K. homecare market place. As 
communicated previously, we are working with Piper Jaffray to assess the best 
way to use our capital resources to maximize shareholder value. The Board of 
Directors remains confident in the Company's ability to realize opportunities in 
the homecare market and achieve its strategies for growth in the years ahead." 
 
 
Conference Call Information -- November 24, 2009 at 10:00AM EST / 3:00PM GMT: 
 
 
Allied invites all those interested in listening to management's discussion of 
the results to join the call by dialing (877) 407-0778 for domestic 
participants, and (201) 689-8565 for international participants today, November 
24, 2009, at 10:00AM EST / 3:00PM GMT. Participants may also access a live 
webcast of the conference call through the "Investors" section of Allied 
Healthcare's Website: www.alliedhealthcare.com. A replay will be available for 
one week following the call by dialing (877) 660-6853 for domestic participants, 
and (201) 612-7415 for international participants. When prompted, please enter 
account number 286 and conference ID number 338036. The presentation will be 
available and archived on the Company's website for ninety days. 
 
 
In addition to disclosing results of operations that are determined in 
accordance with generally accepted accounting principles ("GAAP"), this press 
release also discloses non-GAAP results of operations that exclude or include 
certain charges. These non-GAAP measures adjust for foreign exchange effects. 
Management believes that the presentation of these non-GAAP measures provides 
useful information to investors regarding the Company's results of operations, 
as these non-GAAP measures allow investors to better evaluate ongoing business 
performance. Investors should consider non-GAAP measures in addition to, and not 
as a substitute for, financial measures prepared in accordance with GAAP. A 
reconciliation of the non-GAAP measures disclosed in this press release with the 
most comparable GAAP measures are included in the financial tables included in 
this press release. 
 
 
ABOUT ALLIED HEALTHCARE INTERNATIONAL INC. 
 
 
Allied Healthcare International Inc. (http://www.alliedhealthcare.com) is a 
leading provider of flexible healthcare staffing services in the United Kingdom. 
Allied operates a community-based network of over one hundred ten branches with 
the capacity to provide carers (known as home health aides in the U.S.), nurses, 
and specialized medical personnel to locations covering approximately 90% of the 
U.K. population. Allied meets the needs of private patients, community care, 
nursing and care homes, and hospitals. 
 
 
FORWARD-LOOKING STATEMENTS 
 
 
Certain statements contained in this news release may be forward-looking 
statements. These forward-looking statements are based on current expectations 
and projections about future events. Actual results could differ materially from 
those discussed in, or implied by, these forward-looking statements. Factors 
that could cause actual results to differ from those implied by the 
forward-looking statements include: general economic and market conditions; 
Allied's ability to continue to recruit and retain flexible healthcare staff; 
the H1N1 influenza virus which may result in staff being unable to perform 
services due to their own illness or due to the illness of patients and may 
reduce our revenues; Allied's ability to enter into contracts with local 
government social services departments, NHS Trusts, hospitals, other healthcare 
facility clients and private clients on terms attractive to Allied; the general 
level of demand for healthcare and social care; dependence on the proper 
functioning of Allied's information systems; the effect of existing or future 
government regulation of the healthcare and social care industry, and Allied's 
ability to comply with these regulations; the impact of medical malpractice and 
other claims asserted against Allied; the effect of regulatory change that may 
apply to Allied and that may increase costs and reduce revenues and 
profitability; Allied's ability to use net operating loss carry forwards to 
offset net income; the effect that fluctuations in foreign currency exchange 
rates may have on our dollar-denominated results of operations; and the 
impairment of goodwill, of which Allied has a substantial amount on the balance 
sheet, may have the effect of decreasing earnings or increasing losses. Other 
factors that could cause actual results to differ from those implied by the 
forward-looking statements in this press release include those described in 
Allied's most recently filed SEC documents, such as its most recent annual 
report on Form 10-K, all quarterly reports on Form 10-Q and any current reports 
on Form 8-K filed since the date of the last Form 10-K. Allied undertakes no 
obligation to publicly update or revise any forward-looking statements, whether 
as a result of new information, future events, or otherwise. 
 
 
 
 
                    ALLIED HEALTHCARE INTERNATIONAL INC. 
 
CONSOLIDATED STATEMENTS OF CASH FLOWS 
 


(In

thousands) 
 
 
 


Year Ended

September 30, 
 


2009

  2008 
 


------------

=----------- 
 
(Audited) 
 Cash flows from operating activities: 
   Net income 
                       $     10,303 $      8,786 
   Adjustments to reconcile 
net income 
 


to net cash provided by operating

 


activities:

 
Income from discontinued 
 


operations

    (367)           - 
 


Depreciation and amortization

2,590        3,231 
 


Amortization of intangible assets

1,252        1,634 
 


Foreign exchange loss

 7            - 
 


Increase (decrease) in provision

 


for allowance

for doubtful 
 
     accounts                                            360 
     (167) 
 
    Loss on sale of fixed assets                          20 
    166 
 
    Stock based compensation                             537 
 812 
 
    Deferred income taxes                                117 
88 
   Changes in operating assets and 
 


liabilities, excluding the

effect 
 


of businesses acquired and sold:

 


(Increase) decrease in

accounts 
 
     receivable                                       (4,281) 
 1,579 
 


Decrease (increase) in prepaid

 


expenses and other assets

                        2,318       (3,488) 
 


Increase (decrease) in

accounts 
 
     payable and other liabilities                     2,867 
(3,779) 
 


------------

=----------- 
 
 


Net cash provided by continuing

 


operations

                                   15,723        8,862 
 


Net cash (used

in) provided by 
 
       discontinued operations                             - 
        (561) 
 


------------

=----------- 
 


Net cash provided by operating

 


activities

                               15,723        8,301 
 
                      ------------ ------------ 
 
 Cash flows from investing 
activities: 
 
  Capital expenditures                                (2,850) 
  (3,344) 
   Proceeds from sale of business held 
 


in escrow and

designated for debt 
 


repayment

116       53,638 
   Proceeds from sale of property and 
 


equipment

                                        1           50 
   Payments on 
acquisitions payable                    (1,082)           - 
 
                               ------------ ------------ 
 
                            ------------ ------------ 
 


Net cash (used

in) provided by 
 


investing activities

(3,815)      50,344 
 
=----------- ------------ 
 
 Cash flows from financing activities: 
 
Payments under revolving loan, net                       -      (24,664) 
 
Payments under invoice discounting 
 


facility, net

                 -       (4,458) 
   Principal payments on long-term debt 
               -      (23,678) 
   Proceeds from sale of interest rate 
 
swap agreements                                         -          617 
 
                                          ------------ ------------ 
 
 
Net cash used in financing 
 


activities

         -      (52,183) 
 
=----------- ------------ 
 
 Effect of exchange rate on cash 
      (2,834)        (504) 
 
=----------- ------------ 
 
 Increase in cash 
       9,074        5,958 
 
 Cash and cash equivalents, beginning 
 of 
year                                              26,199       20,241 
 
                                         ------------ ------------ 
 
 Cash 
and cash equivalents, end of 
 year 
$     35,273 $     26,199 
 
============ ============ 
 
 Supplemental cash flow information: 
   Cash 
paid for interest                        $        405 $      1,143 
 
                                      ============ ============ 
 
   Cash 
paid for income taxes, net               $      1,102 $      4,872 
 
                                      ============ ============ 
 
 
 
 
 
                  ALLIED HEALTHCARE INTERNATIONAL INC. 
 
  CONSOLIDATED BALANCE SHEETS 
 


(In thousands, except per

share data) 
 
 
 


September

30, September 30, 
 


2009

      2008 
 


------------

=----------- 
 


ASSETS

(Audited) 
 Current assets: 
   Cash and cash equivalents 
 $     35,273 $     26,199 
   Restricted Cash 
         -          136 
   Accounts receivable, less allowance for 
 
doubtful accounts of $839 and $823, 
 


respectively

             19,594       17,774 
   Unbilled accounts receivable 
          11,572       15,892 
   Deferred income taxes 
          389          474 
   Prepaid expenses and other assets 
     1,188        1,375 
   Assets of discontinued operations 
      -          182 
 
=----------- ------------ 
 


Total current assets

   68,016       62,032 
 
 Property and equipment, net 
    7,756        8,574 
 Goodwill 
95,649      109,292 
 Other intangible assets, net 
1,646        3,345 
 Taxes receivable 
 -           19 
 


------------

=----------- 
 
    Total assets                                $    173,067 $ 
  183,262 
 


============

============ 
 
 


LIABILITIES AND SHAREHOLDERS' EQUITY

 
 Current 
liabilities: 
 
  Accounts payable                              $      1,186 $ 
    1,614 
   Accrued expenses, inclusive of payroll and 
 


related

expenses                                   24,304       28,244 
   Taxes 
payable                                          201            - 
 
Liabilities of discontinued operations                   -          624 
 
                                           ------------ ------------ 
 
Total current liabilities                         25,691 
30,482 
 
 
Deferred income taxes                                    103 
   110 
 


------------

=----------- 
 
    Total liabilities                                 25,794 
   30,592 
 


------------

=----------- 
 
 Commitments and contingencies 
 
 Shareholders' 
equity: 
   Preferred stock, $.01 par value; authorized 
 


10,000 shares,

issued and outstanding 
 


- none

     -            - 
   Common stock, $.01 par value; authorized 
 


80,000

shares, issued 45,571 shares                   456          456 
   Additional 
paid-in capital                         241,555      241,018 
   Accumulated 
other comprehensive (loss) income      (14,418)       1,819 
   Accumulated 
deficit                                (78,026)     (88,329) 
 
                                ------------ ------------ 
 
                                  149,567      154,964 
   Less cost of 
treasury stock (585 shares)            (2,294)      (2,294) 
 
                               ------------ ------------ 
 


Total

shareholders' equity                       147,273      152,670 
 
                                   ------------ ------------ 
 


Total

liabilities and shareholders' equity  $    173,067 $    183,262 
 
                                   ============ ============ 
 
 
 
 
            ALLIED HEALTHCARE INTERNATIONAL INC. 
 
CONSOLIDATED STATEMENTS OF OPERATIONS 
 


(In thousands,

except per share data) 
 
 
 


Three Months

Ended   Year Ended September 
 


September

30,         September 30, 
 
=-------------------  -------------------- 
 
2009       2008       2009       2008 
 
=--------  ---------  ---------  --------- 
 
                               (Audited) 
 
  Total revenues                $ 
69,845  $  74,968  $ 249,810  $ 298,577 
 
=--------  ---------  ---------  --------- 
 
   Gross profit 
    21,196     22,911     76,348     90,385 
 
   Selling, general and 
 
administrative expenses         17,010     18,570     63,234     77,655 
 
                           ---------  ---------  ---------  --------- 
 
 
Operating  income               4,186      4,341     13,114     12,730 
 
 
Interest and other 
 
   (expense) income, net              (14)       264 
  427        393 
 
 
  Foreign exchange expense           (137)      (435) 
  (197)      (586) 
 


--------- ---------

=--------  --------- 
 
 


Income before income taxes

 


and

discontinued 
 
     operations                     4,035      4,170     13,344 
    12,537 
 
 
  Provision for income taxes        1,098      1,279 
3,408      3,751 
 


--------- ---------

=--------  --------- 
 
   Income from continuing 
 


operations

            2,937      2,891      9,936      8,786 
 
      ---------  ---------  ---------  --------- 
 
   Discontinued 
operations: 
 


Income from discontinued

 


operations, net of taxes

        -          -        367          - 
 
=--------  ---------  ---------  --------- 
 
 


Net income

 $   2,937  $   2,891  $  10,303  $   8,786 
 
=========  =========  =========  ========= 
 
 Basic income per share 
of 
 common stock from: 
 


Income from continuing

 


operations

              $    0.07  $    0.06  $    0.22  $    0.20 
 


Income from

discontinued 
 
       operations                       -          -       0.01 
         - 
 


--------- --------- ---------

=-------- 
 
      Net income                $    0.07  $    0.06  $    0.23  $ 
   0.20 
 


========= ========= =========

========= 
 
 
 Diluted income per share of 
 common stock from: 
 
Income from continuing 
 
       operations               $    0.07  $    0.06 
$    0.22  $    0.19 
 


Income from discontinued

 


operations

                   -          -       0.01          - 
 
         ---------  ---------  ---------  --------- 
 


Net income

       $    0.07  $    0.06  $    0.23  $    0.19 
 
     =========  =========  =========  ========= 
 
 Weighted average number 
of 
 common shares outstanding: 
 
      Basic                        44,986 
   44,986     44,986     44,986 
 


=========

=========  =========  ========= 
 
      Diluted                      45,074 
 45,086     45,011     45,078 
 


=========

=========  =========  ========= 
 
 
 
 
 
Allied Healthcare International Inc. 
Sandy Young 
Chief Executive Officer 
Paul Weston 
Chief Financial Officer 
UK 00-44-1785 810-600 
sandyyoung@alliedhealthcare.com 
paulweston@alliedhealthcare.com 
or 
The Investor Relations Group 
Adam Holdsworth 
212-825-3210 
or 
Cenkos Securities plc (Nominated Advisor) 
Elizabeth Bowman 
London: 00-44-20-7397-8928 
or 
Ian Soanes 
London: 00-44-20-7397-8924 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 FR EADFLALFNFFE 
 


Allied Healthcare (LSE:AHI)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Allied Healthcare Charts.
Allied Healthcare (LSE:AHI)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Allied Healthcare Charts.